14 Aug Guide to Raw Material Specification Sheets
A specification sheet can look complete and still leave a formulation exposed. A headline assay, botanical name and country of origin may be enough to identify an ingredient for early sourcing, but they do not necessarily establish whether it is suitable for a specific finished product, market or manufacturing process. This guide to raw material specification sheets sets out what B2B nutrition buyers should review before a material moves from enquiry to approved supply.
For procurement, product development and quality teams, the specification is the agreed technical baseline. It defines what the supplier is expected to provide batch after batch. It should be reviewed alongside the certificate of analysis, relevant declarations and supplier quality documentation, rather than treated as a stand-alone sales document.
What a raw material specification sheet is for
A raw material specification sheet records the expected characteristics and acceptance criteria for an ingredient. In a nutraceutical supply chain, this usually covers identity, physical properties, chemical composition, microbiological limits, contaminants, storage requirements and shelf life. Depending on the material, it may also address allergen status, organic certification, GMO status, irradiation, solvents, carriers and regulatory declarations.
Its central purpose is control. A purchase order may state “creatine monohydrate” or “ashwagandha extract”, but the specification clarifies the grade required. For creatine, this could include assay, particle size, bulk density and impurity limits. For an extract, it may define the botanical source, plant part, extraction ratio, standardised marker compounds and permitted excipients.
A useful specification therefore enables three decisions: whether the material fits the formulation, whether it meets internal quality requirements, and whether each delivered batch can be accepted against an agreed standard.
Specification sheet versus certificate of analysis
These documents are closely related but serve different purposes. Confusing them creates avoidable approval gaps.
A specification sheet is the target. It states the approved ranges or limits, such as an L-glutamine assay of 98.0-102.0%, a moisture maximum, or a total plate count limit. It should remain relatively stable unless the material, process or agreed quality standard changes.
A certificate of analysis, often abbreviated to CoA, is batch-specific evidence. It reports the results obtained for a particular lot and should show that the lot meets the specification. A CoA that reports “conforms” can be acceptable for selected parameters where a validated supplier arrangement is in place, but numerical results are generally more useful for critical attributes and trending.
A technical data sheet may contain handling guidance, typical values or general product information. It is helpful, but it is not automatically a controlled specification. Buyers should establish which document is the current approved standard and ensure the supplier version, issue date and revision number are visible.
The core sections to review
The level of detail should reflect the ingredient’s risk profile and intended use. A simple mineral salt and a complex botanical extract should not be assessed in exactly the same way. Nevertheless, several sections should be present in most food and supplement raw material specifications.
Identity and ingredient definition
Start with unambiguous identification. The sheet should state the correct ingredient name and, where relevant, the chemical name, CAS number, molecular formula, botanical Latin name, plant part and extract ratio. For vitamins, amino acids and specialty compounds, the precise form matters: magnesium bisglycinate is not interchangeable with magnesium oxide, and vitamin K2 MK-7 requires a different identity discussion from vitamin K1.
For plant extracts, check whether the stated standardisation matches the formulation claim. “Green tea extract” is broad. A specification identifying Camellia sinensis leaf extract standardised to a defined polyphenol or EGCG level is commercially and technically more meaningful.
The composition statement should also identify carriers, flow agents, processing aids and other added materials. A 95% botanical extract supported on maltodextrin may be suitable for one product but unsuitable for another where a higher active concentration, different allergen position or organic status is required.
Assay, active content and physical characteristics
Assay limits show the expected concentration of the principal compound or marker. Review both the method and the range. Wide ranges may be appropriate for natural materials with normal agricultural variation, but may create formulation challenges where dosage accuracy is tight.
Physical properties can be equally important in production. Particle size, mesh, bulk density, tapped density, solubility, pH, loss on drying, water activity, colour and odour may affect blending, encapsulation, tabletting and finished-product appearance. A specification that confirms assay but omits particle size may be insufficient for a direct-compression tablet application.
Use “typical” values with care. They indicate what is commonly observed, not necessarily what the supplier guarantees. Where a characteristic is critical to your process, it should appear as an acceptance criterion with a defined test method or agreed measurement basis.
Microbiological and contaminant limits
Microbiological limits should align with the material category, intended use and risk assessment. Common parameters include total viable count, yeasts and moulds, Enterobacteriaceae, E. coli, Salmonella and Staphylococcus aureus. The appropriate limits vary. A dry amino acid powder, a fruit powder and a spray-dried probiotic blend do not carry the same microbiological expectations.
Contaminant testing requires similar context. Specifications may cover heavy metals, pesticide residues, polycyclic aromatic hydrocarbons, mycotoxins, residual solvents and foreign matter. For botanicals, mushrooms, algae, fruit powders and marine-derived materials, the relevant contaminant profile may be more extensive than for highly purified synthetic compounds.
Do not rely on a single combined “heavy metals” figure where individual limits are needed for lead, cadmium, mercury and arsenic. The method, reporting unit and whether the result refers to total or inorganic arsenic can alter the compliance assessment.
A practical guide to raw material specification sheets for formulators
The most effective review begins with the finished-product brief, not the supplier document. Define the required active level, dose, target markets, permitted excipients, dietary positioning, label claims and process constraints. Then compare the offered material against those requirements.
For example, a protein powder intended for a flavoured sports nutrition blend may tolerate some natural variation in colour and flavour, while a clear ready-to-mix drink demands much tighter control of solubility, sensory profile and sediment. Likewise, an organic requirement is not met simply because an ingredient is described as natural. The material must be supplied under the appropriate certified organic chain of custody, with documentation that supports the intended market.
Where an ingredient is being substituted, compare specifications line by line. Similar names do not confirm equivalence. Differences in standardisation, mesh size, carrier content, source material or analytical method can affect dosage calculations, labelling, processing and finished-product stability.
Questions to resolve before approval
A specification should allow a buyer to ask focused questions rather than make assumptions. If a marker compound is specified, ask whether the stated result is measured by a recognised method and whether the method is suitable for the matrix. If the sheet gives a residual solvent limit, confirm which solvents are relevant to the extraction process. If a material is described as allergen-free, establish whether this refers to formulation only or includes site-level cross-contact controls.
Country of origin also needs clear interpretation. It may refer to the country where the crop was grown, where the raw material was processed, or where the final ingredient was packed. Each can matter to supply-chain risk assessment and customer declarations.
For animal nutrition applications, confirm that the specification and accompanying declarations support the intended species, product category and market requirements. Human food supplement documentation should not automatically be assumed to cover feed use, and the reverse is equally true.
Change control and ongoing supply
Approval should not end with the first compliant batch. A dependable supplier will operate change control for matters that could affect the agreed material, including source, manufacturing site, processing method, specification limits, analytical methods, packaging or shelf life. Buyers should establish what notice is required and which changes require formal reapproval.
Version control is often overlooked. Retain the approved specification with its revision number, and ensure purchasing, quality and product development work from the same version. When a new issue is received, assess whether the amendment is editorial or technically significant. A revised test method, altered active range or new carrier should trigger a documented review.
At Nutra Ingredients Ltd., specification-led sourcing supports consistent discussion between procurement teams, contract manufacturers and product developers across conventional and organic raw material lines. The aim is not paperwork for its own sake, but a clear, trade-ready standard for the ingredient being supplied.
A well-reviewed specification sheet gives teams a shared reference point when commercial pressure, formulation requirements and quality risk need to be balanced. Ask for the detail that matters to your product, agree it before purchase, and keep the approved standard active throughout the supplier relationship.